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There is increasing evidence that exposure to organic aller-
gens may induce or exacerbate lesional skin in patients with 
atopic dermatitis. In this study, patients with atopic dermati-
tis were patch tested to 11 common organic allergens and to 
control chambers containing 0.4% phenol and 50% glycerin 
in 0.9% saline. In biopsies from positive patch test reactions, 
patch test control skin, lesional eczematous and non-lesional 
skin from atopic individuals, and normal skin from non-
atopic volunteers, the presence and distribution of macro-
phages (RFD7+), dendritic cells (RFD1 +), and Langerhans 
cells, and the expression of the low-affinity receptor for IgE 
(CD23) were investigated. 
In patch test reactions and lesional skin samples, inflamma-
tory infiltrates of diffusely distributed macrophages 
(RFD7+), dendritic cells (RFD1+), T lymphocytes 
(RFTmix+), and Langerhans cells (CD1+) were seen, the 
latter being present in both the epidermis and the dermis. 
For many years the role of IgE in the pathogenesis of atopic dermatitis (AD) has been controversial. Approxi-mately 80% of patients with AD show an immediate type hypersensitivity reaction to environmental aller-gens when given intradermally as a skin prick test, to-
gether with elevated serum IgE levels with a specificity to these 
allergens [1] . Despite this, the cellular characteristics of the eczema-
tous lesion are repeatedly described as that of a delayed-type hyper-
sensitivity reaction, with the T lymphocyte as the predominant cell 
type in the dermal infiltrate [2 - 4] . Epicutaneous patch testing with 
aeroallergens such as house dust mite (Dermatophagoides pterol1Ys-
sinus) produces an eczematous reaction, which also has the dy-
namics and histology of a delayed-type hypersensitivity reaction 
[5-9]. 
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The numbers of Langer hans cells were reduced in the epider-
mis :and increased in the dermis in patch test reactions and 
lesional skin compared to their controls. Double staining 
reve:aled a change in the distribution of CD23 antigen. In 
patch test control and non-Iesional biopsies many macro-
phages and only a few Langerhans cells within the dermal 
infiltrates expressed this antigen. In patch test reaction and 
lesional skin samples, however, the proportion of CD23+ 
dermal Langerhans cells had increased compared to macro-
phages. Furthermore, in these latter samples an increased 
proportion of dermal CD 1 + cells expressed the dendritic cell 
(RFD 1 +) marker. These results show that following antigen 
challenge there are marked similarities between the pheno-
type of the cellular infiltrate in patch test reaction and le-
sion:al skin biopsies, and also demonstrate a changing distri-
bution of CD23 on antigen-presenting cells.] Invest Dermatol 
99:184-188,1992 
It has been shown that AD can relapse following environmental 
Contact with specific allergens, and the dermatosis remits if these 
allergens are removed from the patient'S environment [6,10] . The 
aeroallergens in these and other studies [5,7,8,11,12] were identi-
fied by their ability to induce both positive skin prick test reactivity 
and positive patch test reactions. Delayed patch test reactions oc-
curred only to allergens to which the patient reacted when chal-
lenged in the skin prick test. Significantly, these reactions uni-
formly failed to exhibit the clinical or histologic features of an 
immediate hypersensitivity reaction when analyzed at 48 h. It has 
therefore been suggested that the skin lesions of AD result from a 
chronic delayed hypersensitivity reaction involving epidermal Lan-
gerhans cells that present antigen to sensitized T lymphocytes [13]. 
Though the positive patch test reaction and lesional skin in pa-
tients with AD do not exhibit the clinical or histologic features of a 
type 1 hypersensitivity reaction, IgE may playa role in presenting 
aeroallergens. In a recent in vitro study, cell-bound IgE on Langer-
hans cells was required to initiate T-cell responses to allergens [14] . 
Further work has shown that in patients with AD the ratio of 
CD 1-+ /IgE+ cells in the epidermis decreases after 1 week of treat-
ment with topical corticosteroid, with complete disappearance of 
IgE+ cells after 2 weeks [15]. Low-affinity receptors for IgE have 
been identified on epidermal Langerhans cells as well as on macro-
phages, Band T lymphocytes, and platelets [16] . This has been 
observed in biopsies both from patients with AD and non-atopic 
individuals [17] . Although the precise function of these receptors in 
AD is unclear, it could be hypothesized that they may playa role in 
the presentation of antigen to activated T lymphocytes. In this 
study, we have investigated CD23 expression on Langerhans cells, 
dendritic cells (RFDl +), and macro phages (RFD7+) in both posi-
ti"e patch test reactions and non-patch tested lesional skin from 
patients with AD. We also wished to study the relative distribution 
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of these subsets of non-lymphoid immunocompetent cells in the 
positive patch test reaction, patch test control, lesional, and non-le-
sional biopsies. 
MATERIALS AND METHODS 
Patients Fifty-six patients (37 male, 19 female) with atopic der-
matitis (age range, 22 - 38 years) diagnosed according to the criteria 
of Hanifin and Rajka [18] were studied. Patients had moderate to 
severe dermatitis requiring daily topical corticosteroids. Seven of 
the patients had bronchial as thma and 20 suffered from seasonal 
allergic rhinitis. .. 
All patients were skl11 prick test~d on the volar aspect of the 
non-dominant forearm to the followl11g common mhaled allergens: 
Cladosporium herbartlm, Alternaria telnlis, Candida albicans, Dermato-
phagoides pteronyssinus, Dermatophagoides jarinae? cat and dog dander, 
birch and plane tree extracts, rye grass, and ttmothy grass pollens 
(Pharmacia Ltd.), using 1 % histamine as a positive control and 0.4 % 
phenol and 50% glycerin in 0.9% saline as a negative contro!' 
Aeroallergen Patch Testing and Skin Biopsies All patients 
had not applied topical corticosteroids to the areas to be patch tested 
for 2 weeks prior to testing and none had received ultra-violet 13 
irradiation, PUV A, or treatment with immunosuppressive agents in 
the previous month . . . . 
Epicutaneous patch testl11g was perfor.me? O? all pattents .wah 
8-mm Finn chambers (Epltest Ltd, Helsl11b, Fmland) contalmng 
the same allergens in the same concentrations as used for skin prick 
testing, on clinically normal skin on both sides of the upper back, 
one side having been prepared by Sellotape stripping 15 times . One 
chamber on either side contained diluent as contro!' The patch tests 
were examined at 48 h and the positive patch test reactions were 
graded according to the International Contact Dermatitis Group 
guidelines [19]. . . 
Ten patients consented to have 4-mm .punch bIOpSies from the 
Sellotape-strippe~ poslt.lve pa.tch test reactlO~ and pat~h test control 
sites. For companson, SIX pattents With atopic dermatttts who were 
skin prick test positive had biop.sies tak~n from non-tap~-stripped 
lesional eczematous and non-leslOnal skl11. Non - tape-stnpped skin 
biopsies from five age- and sex-matched normal individuals with nO 
personal or family history of atopy and who were skin prick test 
negative acted as further control samples. Specimens were placed in 
embedding compound (Bright Instruments Company Ltd, UK), 
snap frozen in liquid nitrogen, and stored at -70 ° C. Six-microme-
ter sections were cut, mounted on poly-l-lysine-coated slides, air 
dried for 30 min, fixed in chloroform: acetone (1 : 1), and stored at 
-20°C. 
Immunostaining The following panel of monoclonal antibod-
ies (MoAb) were used: CDl (Dakopatts, Ltd), which identifies thy-
mocytes and Langerhans cells; CD23 (Dakopatts) (FceRll), a 
marker for the low-affinity receptors for IgE; RFD1 (Royal Free 
Hospital School of Medicine [RFJ, London), which labels dendritic 
antigen-presenting cells; RFD7, a marker for tissue macrophages; 
and RFTmix, which is a pan T-cell marker (Table I). 
For the staining of individual cell types, the indirect alkaline 
phosphatase method was used. The primary antibody diluted in 
Tris-buffered saline (TBS) was added to the reaction and incubated 
for 30 min. After washing in TBS for 2 min, a second layer of rabbit 
anti-mouse immunoglobulin (Dakopatts Ltd.) was applied and in-
cubated for 30 min, washed for 2 min, and followed by a third layer 
of an alkaline phosphatase-mouse anti-alkaline phosphatase corn-
plex (AP AAP; Dakopatts) for a further 30 min . Fast red (Sigrna 
Ltd.) was used as a developer. Sections were counterstained in he-
matoxylin and mounted in phosphate-buffered saline/glycerol 
(9: 1). For controls, the first layer was replaced by TBS. Double 
staining was performed for CD1 /C D23, RFD7/CD23, using 
APAAP and peroxidase methods sequentially. Peroxidase staining 
identified CD23 expression and AP AAP identified RFD7 and CD 1. 
Double immunofluorescence was performed using a mixture of 
class-specific second layers conjugated with fluorescein isothio-
cyanate (FITe) and tetramethylrhodamine (TRITe) to identify 
RFDt+/CD23+ and RFDt+/CDt+ cells. 
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Table I. List of Monoclonal Antibodies Used in the Study 
Reactivity in 
Name CD Subclass Source Normal Tissues 
RFDl IgMp RFHSM' Epitope of HLA-DR 
with restricted ex-
pression to dendritic 
cells 
RFD7 IgGl RFHSM Mature tissue macro-
phages 
RFT6 CDl IgGy RFHSM Thymocytes and Lan-
gerhans cells 
RFTmix CDS,8, IgGy RFHSM Pan T lymphocyte 
CDll 
FceR11 CD23 IgG1y Dakopatts Low-affinity IgE recep-
UK Ltd. tor 
• RFHSM, Royal Free Hospital School of Medicine. 
Quantification of the distribution of specific cell rypes was per-
formed using an image analyzer to define and measure framed areas 
of section (one high-power field [X 400] below the dermo-epider-
mal junction) to be counted and point counts made of the positively 
stained cells in at least six areas. The results were expressed as the 
number of cells per unit area. Counts of RFD 1 + cells were) per-
formed using a fluorescence microscope and the results expressed as 
the number of cells per high-power view (X 400). 
Statistical Methods Where appropriate, statistical differences 
between densities of the cellular infiltrates were determined using 
the Wilcoxon sign rank test for paired data; a value of p < 0 .05 was 
considered significant. 
RESULTS 
All patients with AD were skin prick test positive to one or more 
inhalant allergens. Seventeen patients showed positive patch test 
reactions to one or more epicutaneously applied allergens. The 
commonest reactions were to Dermatophagoides pteronyssinus and 
Dermatophagoides jarinae, cat dander, Candida albicans and Cladospor-
ium herbanlm, and rye grass pollen. T en patients reacted to more 
than one allergen and four patients developed positive patch test 
reactions on both the Sellotape-stripped and non-stripped sides, 
whereas no patient reacted on the non-stripped side only (Table II). 
Table II. Details of Patients who Developed Positive Patch 
Test Reactions· 
Patient Skin Prick 
Number/ Age Reactivity 
1/ 30 DP,DF,P 









11 /28 AT,CA,DF,C,R 
12/ 39 DP,DF,B,R,T,D 
13/30 R,C,DP,DF,T,D 

























• AT, Allemaria let",is; B, birch; C, cat dander; CA, Ca"dida albicallS; CH, Cladospor-
ill'" It .rba",,,,; D, dog dander; DF, Dennatopltagoidesjari"ae; DP, Dermatopltagoides plerotl-
yssitllls; PT, plane tree; R, rye grass; T, timothy grass. 
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Figure 1. Numbers of cells staining positive with monoclonal antibodies 
against Langerhans cells (CDl +), macrophages (RFD7+), T lymphocytes 
(RFTmix+), CD23+ cells, and dendritic cells (RFD1+) within the dermal 
infiltrate of non-les ional atopic skin and normal (non-atopic) control skin 
samples .• p < 0.05. 
In all cases, positive patch test reactions occurred only to allergens to 
which the patient was skin prick tes t positive. The positive reactions 
consisted of erythema and papules in all patients, vesiculation in 
fo ur; no urticarial reactions were observed. 
Immunohistology 
COl1t rol Samples: There was a significant increase in the number of 
macrophages (RFD7+) and CD23+ cells within the dermis and of 
the total number of Langerhans cells in the sections of non-Iesional 
skin compared to normal control skin (p < 0.05), whereas the in-
crease in the number of T lymphocytes and dermal dendritic 
(RFD1 +) cells in non-I esional compared to normal control skin was 
not significant (Fig 1). 
Comparisol1 between Lesional al1d Non-Lesional Samples: There was a 
significant increase in the total number of tissue Langerhans cells, 
macrophages (RFD7+), and CD23+ cells in the dermis in lesional 
skin compared to non-lesional samples (p < 0.05); the increases in 
the numbers ofT lymphocytes and dermal dendritic cells (RFDl +) 
in the lesional samples 'were not significant (Fig 2a). There was also 
a non-significant reduction in the number of epidermal Langerhans 
cell s and an increased number of dermal Langerhans cells in lesional 
skin compared to non-Iesional samples; 12.6 ± 4.4 CDl + cells per 
unit area and 7.0 ± 3.0 CD l + cells per unit area in the epidermis of 
non- lesional and lesional skin, respectively; 2.9 ± 2.4 and 4.4 ± 2.2 
CD 1 + cell s per unit area in the dermis of non-Iesional skin and 
lesional skin, respectively. 
Patch Test Reactions Compared to Patch Test Control Samples: There 
were significantly more T lymphocytes (p < 0.05) and macro-
phages (RFD7+) (p < 0.001). in patch test reaction samples com-
pared to patch test control biopsies (Fig 2b) . Compared to patch test 
control samples the number of Langerhans cells in patch test reac-
tions was reduced in the epidermis and increased in the dermis, 
though the changes were not statistically significant: 38 ± 30.5 and 
8.7 ± 4.0 in the epidermis and the dermis of patch test control, 
respectively; 18.0 ± 14.0 and 9.5 ± 4.7 in the epidermis and the 
dermis of patch test reactions, respectively. 
CD23 Expressiol1 : The total number of cells expressing CD23 in 
the skin of patch test reactions and lesional skin samples was higher 
than in their respective controls (Fig 2a,b). T able III shows the 
distribution of CD23+ cells within the epidermis and the dermis. 
Double immunofluorescence staining showed that there was no 
statistically significant difference in the number of cells staining 
CD23+ antigen-presenting cell s in non-Iesional and normal con-
trol samples; there were < 5% and 2% dendritic cells (RFD1+), 
10% and 6% CD l+ cells, and 30% and 40% macrophages 
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Figure 2. Results on individual patients for the numbers of dermal Langer-
hans cells (CDl+), macrophages (RFD7+), T lymphocytes (RFTmix+), 
CD23+ cells, and total number of dendritic cells (RFDl+) within the 
sections of (aJ non-lesional compared to lesional atopic skin. and (b) patch 
test control compared to positive patch test reactions. ns, nonsignificant; 
'p < 0.05; IlOrizol1taiiines, median values. 
(RFD7+), respectively, in the normal skin and non-Iesional sam-
ples. 
In lesional skin, however, the proportions of dendritic cells 
(RFD1+) and CD1+ cells expressing CD23 rose to 60% and 50%, 
respectively, whereas the proportions of macrophages (RFD7+) fell 
to <:: 10% (Fig 3a). This shift in the expression of CD23 was also 
observed when patch test reaction samples were compared to patch 
test control samples (Fig 3b). These results demonstrate a shift in 
CD23 expression from tissue macrophages in patch test control and 
non-Iesional samples to Langerhans cells and dendritic cells 
(RFD 1 +) in both patch test reaction and lesional skin samples. 




pa.tch test control 
pa.tch test reaction 
Number of Cells/Unit Area 
(X 105/ square micron) 
Epidermis 
o 
0.5 ± 0.3 
0.1±0.14 
0.31 ± 0.5 
1.03 ± 0.7 
Dermis 
0.3 ± 0.7 
1.7 ± 2.8 
3.3 ± 4.0 
6.8 ± 3.8 
11.0 ± 3.4 
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Figure 3. The percentage of Langerhans cells (CDl+), macrophages 
(RFD7+), and dendritic ce lls (RFDl+) that are CD23+ within the dermis 
of (aJ non-lesional compared to lesional atopic skin, and (bJ positive patch 
test reactions compared to patch test control samples. 
Double staining with the dendritic cell marker (RFD1) and CDl 
MoAb revealed very few positive cells in the epidermis. In contrast, 
it was observed that the dendritic cell (RFDl +) antigen emerged on 
a significant proportion of Langerhans cells in the dermis of patch 
test reaction (60%) and lesional skin (70%) samples, compared to 
44% in control skin (p < 0.05). 
DISCUSSION 
This study confirms previous reports that the patch test reaction to 
aeroallergens and the lesional skin in patients with AD exhibit char-
acteristic features of a delayed type IV hypersensitivity reaction. It 
goes further in revealing 1) the distribution of immunocompetent 
cells in patch tested and lesional skin; 2) similarities in the pheno-
type of the dermal infiltrate in the patch test reaction and lesional 
skin; 3) a difference between the normal non-atopic skin and the 
non-lesional skin in patients with atopic dermatitis; and 4) a shift in 
the expression of CD23 from tissue macrophages to dendritic cells 
within the dermis. 
Patch test reactions studied by other investigato~s have shown a 
dermal cellular infiltrate of T lymphocytes and CD1+ cells 
[3,6,7,20]. We have demonstrated increased numbers of Langer-
hans cells, macrophages, and lymphocytes in the dermis of patch 
test rea:::tions. Because the patch test samples were obtained from 
Sellotape-stripped skin, a direct comparison with samples taken 
from non-stripped skin is not valid . Despite this, however, it is 
interesting that lesional skin samples contained similar increases 
over their controls in the number of these cell subsets observed in 
patch test reactions compared to patch test controls. The reduced 
numbers of Langerhans cells in the epidermis with increased num-
bers in the dermis of both lesional and patch test reaction biopsies are 
identical to those reported in allergic contact dermatitis [21]. Macro-
phages were diffusely distributed throughout the dennis whereas 
the Langerhans cells and lymphocytes were principally located peri-
vascularly in the upper dermis. These results are consistent with the 
immunohistochemical profile of a delayed hypersensitivity reaction 
[22]. lending weight to the argument that suggests that the clinical 
lesion in AD is a T-cell-mediated hypersensitivity reaction. 
Another finding from this study is the emergence in the dermis of 
both lesional skin and patch test reaction samples of Langerhans 
cells that also express the dendritic cell marker (RFD1). Normal 
skin contains few detectable dendritic cells [23], and Langerhans 
cells are largely confined to the epidermis. In lesional skin of in flam-
matory dermatoses including AD, both Langerhans cells and den-
dritic cells are found in abundance within the dermis, the latter 
being occasionall y observed in the epidermis [24]. C lose histoge-
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netic and functional links seem to exist between Langerhans cells 
and dermal dendritic cells, suggesting inter-differentiation between 
them dependent upon biologic stimuli and other factors [25]. It is 
noteworthy that within the epidermis of patch test reaction and 
lesional skin samples, very few CD1+ RFD1 + cells were identified, 
whereas the reverse was true in the dermis. All patients in this study 
produced immediate hypersensitivity reactions to specific antigens 
when skin prick tested. When these same allergens were applied 
epicutaneously the morphology of the reactions observed at 48 h, 
were eczematous with erythema, papules, and sometimes vesicles, 
rather than showing urticarial lesions typical of the type 1 reaction. 
Gondo [20] has shown that with repeated challenge with the house 
dust mite antigen, a type IV eczematous reaction is produced 24-
48 h after an initial type 1 response. This difference in clinical 
lesions is reflected in the histology of the patch test reaction at 48 h, 
which suggests a delayed T -cell- mediated reaction. This would be 
consistent with an IgE-mediated "late-phase" response and recent 
studies of allergen-induced mast cell activation have shown that the 
terminal stages ofIgE-mediated hypersensitivity reactions are char-
acterized by infiltration of monocytes and lymphocytes [26,27]. It 
seems likely, therefore, that it is the patch test reaction and not the 
immediate prick test reaction that reflects the clinical lesions seen in 
AD. 
Immunoelectron microscopic studies have shown house-dust an-
tigen attached to IgE+ dendritic cells in patch test-positive sites 
[28], although it is unclear as to whether the antigen binds to IgE or 
not. Mudde et al [29] have highlighted the importance of IgE+ 
Langerhans cell in antigen presentation. In their in vitro studies, a 
T-cell response to house-dust mite antigen was only observed in the 
presence of IgE+ Langerhans cells from patients with AD. IgE-
negative Langerhans cell or Langerhans cells from normal controls 
were unable to present house-dust mite antigen. Furthermore, the 
presence of IgE on Langerhans cells correlated with the clinical 
activity of the disease and Langerhans cells from patients with AD 
in clinical remission became IgE negative [30]. 
Recently, low-affinity IgE receptors (Fc.R11/CD23) have been 
demonstrated on Langerhans cells in patients with AD [14] . This 
antigen is not specific for AD and has been identified in non-atopic 
skin [16] . In this study, we have confirmed that the CD23 antigen is 
expressed, albeit weakly, in non-atopic individuals. W e observed 
greater numbers of CD23+ cells in patch test- reaction samples 
compared to lesional skin sections and it is possible that this increase 
is a consequence ofSellotape stripping. Sellotape stripping is known 
to cause a reduction in the number of Langer hans cells in guinea pigs 
[31] without altering the degree of contact sensitivity to DNCB. In 
contrast, we observed that the numbers of LC were actually in-
creased in patch test control compared to non-Iesional skin, sug-
gesting that the effect ofSellotape stripping was minimal , at least in 
terms of the numbers of inflammatory cells within the sections. 
Indeed, we found no significant difference between the non-Ie-
sional skin (non-stripped) and patch test control skin (stripped) for 
the numbers of cell subsets studied (data not shown) although there 
was a significantly greater number of CD23+ cells in the patch test 
control samples. 
In patch test control skin from patients with AD, CD23 was 
found mainly on tissue macrophages (RFD7+) and only a small 
proportion of Langerhans cells and dendritic cells (RFDl +) were 
CD23+. The situation was reversed in lesional skin and patch test -
reaction samples, for which less than 10% of macrophages 
(RFD7+) and up to 80% of Langer hans cells (CD1+) were positive 
for CD23 (Fig 3). Thus our data offer evidence that there is a shift in 
CD23 expression from tissue macrophages to dendritic cells in both 
patch test reaction and lesional skin of patients with AD. 
It is also significant that> 60% of dermal Langerhans cells ex-
pressed the dendritic cell marker (RFD1), whereas few epidermal 
Langerhans cells were positive. RFD1 positivity has been shown to 
be specifically associated with cell s presenting antigen [32-34]. 
Langerhans cells are not constitutively RFD 1 + but become strongly 
positive when activated [35]. Results reported here therefore sug-
gest that antigen presentation by Langerhans cells (CD1+) occurs 
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predominantly within the dermis rather .than in the epidermis. It is 
possible that the presence of antigen wI~hlI1 the epIdermIs of pa-
tients with AD results in an upregulatlon 111 the expressIon of CD23 
antigen on Langerhans cells that migrate to the dermis w~ere they 
are then able to present this antIgen, as eVIdenced by the lI1~reased 
expression of RFD1. Further work, t~erefore, needs to be dIrected 
towards understanding the modulatIOn of the CD23 antigen on 
antigen-presenting cells in the skin of patients with AD. 
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